51st DMDG Open Meeting: Shaping the future of DMPK
WuXi AppTec is excited to participate in the 51st DMDG Open Meeting: Shaping the Future of DMPK, taking place September 2–4, 2025, at Churchill College in Cambridge, UK.
At this premier DMPK forum, WuXi AppTec DMPK will deliver a scientific presentation and present posters—including our work on radiolabeling synthesis and ADME profiling of GLP-1 analogs, showcasing strategies for studying complex peptides used in type 2 diabetes and obesity therapeutics.
WuXi AppTec’s DMPK platform offers fully integrated services—from radiolabeled compound synthesis and quantitative whole-body autoradiography, to in vitro/in vivo metabolite identification (MetID), bioanalysis across novel modalities (e.g., peptides, ADCs, oligonucleotides), and ADME profiling. Our capabilities help advance drug candidates confidently from discovery stages through IND-enabling research.
We look forward to connecting with the DMPK community in Cambridge to explore how our capabilities can support your next breakthrough in pharmacokinetics and metabolism.
To schedule a dedicated meeting with our team, please fill out the form on the right.
